Pharmaceutical systems in the new EU Member States

Report by ÖBIG Health Economics on the health care and pharmaceutical (reimbursement, pricing, distribution) systems in the ten new Member States of the enlarged European Union

The study offers latest information and data on
- Health care organisation and financing
- Key actors in the pharmaceutical system
- Registration of pharmaceuticals
- Reimbursement (positive lists, reimbursement rates, reference price systems, co-payments, pharmacoeconomics)
- Pricing (at manufacturer, wholesale, and pharmacy level)
- Distribution

in
- Cyprus
- Czech Republic
- Estonia
- Hungary
- Latvia
- Lithuania
- Malta
- Poland
- Slovakia
- Slovenia

The report provides 10 concise country reports and a comprehensive benchmarking chapter.

The study is available in German ("Arzneimittelsysteme in den neuen EU-Mitgliedstaaten") and in a shortened English version ("Pharmaceutical Systems in the New EU Member States”).

The table of content may be downloaded below
Download table of content

Client: Federal Ministry of Health and Women

Editor: ÖBIG (Austrian Health Institute)

Place of publication: Vienna

Year of publication: 2005

ISBN: 3-85159-080-5

Number of pages: 130 pages, 20 tables, 15 figures (including 10 flowcharts on the organisation of the pharmaceutical systems)

Reimbursement of expenses: € 45,00

English version ISBN 3-85159-081-3